Home Cart Sign in  
Chemical Structure| 1132935-63-7 Chemical Structure| 1132935-63-7

Structure of Dasabuvir
CAS No.: 1132935-63-7

Chemical Structure| 1132935-63-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ABT-333 is an inhibitor of the RNA-dependent RNA polymerase with IC50 range from 2.2 nM to 10.7 nM.

Synonyms: ABT-333

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Silva Franco, Lucas ; Rodrigues, Daniel Alencar ; Baumart, Gabriela Joras ; de Jesus, Bárbara da Silva Mascarenhas ; Gomes, Flávia Carvalho Alcantara ; Lima, Lídia Moreira , et al.

Abstract: ROCK kinases are key players in neurodegenerative diseases such as Alzheimer’s disease (AD), making them attractive therapeutic targets. In this study, we developed a pharmacophoric map of ROCK inhibitors and highlighted the key affinity sites in ROCK1/2 through molecular modeling. Virtual screening led to the identification of six approved drugs as ROCK inhibitors: ruxolitinib (36), baricitinib (37), ponatinib (38), tivozanib (39), nialamide (40), and tucatinib (41). Ruxolitinib (36) (hROCK1 IC50 = 0.025 μM; hROCK2 IC50 = 0.007 μM) and baricitinib (37) (hROCK1 IC50 = 0.019 μM; hROCK2 IC50 = 0.011 μM) showed the highest potency, while tivozanib (39) displayed 15-fold selectivity for ROCK2 over ROCK1. Molecular dynamics revealed that ruxolitinib (36) forms stable bidentate hydrogen bonds with the ROCK hinge region and has selectivity across the AGC kinase family. Biological assays confirmed ruxolitinib’s (36) safety in neuronal and glial cells and its ability to reduce C3 immunolabeling, a glial inflammation marker, in LPS-treated astrocytes. These findings not only highlight ruxolitinib (36) as a promising candidate for AD but also provide a structural basis for designing novel dual JAK-ROCK inhibitors and pave the way for further in vitro and in vivo studies. Moreover, the validated pharmacophoric map for ROCK inhibition highlights the identification of an affinity pocket that can be useful for the design of new ROCK inhibitors.

Alternative Products

Product Details of Dasabuvir

CAS No. :1132935-63-7
Formula : C26H27N3O5S
M.W : 493.57
SMILES Code : CS(=O)(NC1=CC=C2C=C(C3=CC(N(C(N4)=O)C=CC4=O)=CC(C(C)(C)C)=C3OC)C=CC2=C1)=O
Synonyms :
ABT-333
MDL No. :MFCD27923655
InChI Key :NBRBXGKOEOGLOI-UHFFFAOYSA-N
Pubchem ID :56640146

Safety of Dasabuvir

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P261-P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HEK cells (expressing hERG channels) 1-30 µM Concentration-dependently inhibited hERG current with IC50 of 3.2 µM; partially irreversibly blocked channels in the open state. PMC10143825
Canine left ventricular myocardial cells 3-30 µM 5 min Concentration-dependently prolonged APD50 and APD90, elevated early plateau potential, and reduced V+max, VPh1max, and V−max; induced early afterdepolarizations (EADs) in some cells. PMC10143825
Canine left ventricular myocardial cells 1 µM 15 min Prolonged action potential duration (APD90) reversibly by 7.84±3.09%; irreversibly reduced maximal rates of phases 0 and 1 (V+max and VPh1max). PMC10143825
Genotype 1b (Con1 strain) 1.8 nM 3 days Evaluate the inhibitory effect of ABT333 on genotype 1b HCV subgenomic replicons, showing an EC50 of 1.8 nM PMC4325770
Genotype 1a (H77 strain) 7.7 nM 3 days Evaluate the inhibitory effect of ABT333 on genotype 1a HCV subgenomic replicons, showing an EC50 of 7.7 nM PMC4325770
Canine Left Ventricular Cells 1.2 µM ABT-333 increases action potential duration and provokes early afterdepolarizations via inhibition of I Kr PMC11435406

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02460133 Hepatitis C Virus Phase 4 Active, not recruiting June 2018 -
NCT03423641 - Completed - -
NCT02057003 - Recruiting December 2020 Spain ... More >> Valme University Hospital Recruiting Seville, Spain, 41014 Contact: Karin Neukam, PhD    0034955015799    karin.neukam@gmail.com    Contact: Juan A Pineda, MD    0034955015684    japineda@telefonica.net Less <<
NCT02758509 - Completed - -
NCT03149289 - Completed - -
NCT02555943 Chronic Hepatitis C Infection ... More >> HBV Coinfection Hepatitis B Reactivation Less << Phase 2 Phase 3 Recruiting December 2018 China, Hong Kong ... More >> Humanity and Health GI and Liver Centre Recruiting Hong Kong, Hong Kong, China, 00852 Contact: Cheng Wang, M.D. PhD    (852)28613777    doc_chengwang@126.com    Contact: Yudong Wang    (852)28613777    ydwang@connect.hku.hk Less <<
NCT02333292 - Recruiting December 2020 Spain ... More >> Valme University Hospital Recruiting Seville, Andalusia, Spain, 41014 Contact: Karin I Neukam, Dr    0034955015871    karin.neukam@gmail.com    Contact: Juan A Pineda, Dr    0034955015684    japineda@telefonica.net Less <<
NCT03710252 Chronic Hepatitis C Phase 4 Completed - -
NCT02194998 HIV Infections Phase 2 Completed - United States, Alabama ... More >> Alabama CRS Birmingham, Alabama, United States, 35294 United States, California UCLA CARE Center CRS Los Angeles, California, United States, 90035 United States, Colorado University of Colorado Hospital CRS Aurora, Colorado, United States, 80045 United States, District of Columbia Whitman-Walker Health CRS Washington, District of Columbia, United States, 20005 United States, Illinois Rush University CRS Chicago, Illinois, United States, 60612 United States, Maryland Johns Hopkins University CRS Baltimore, Maryland, United States, 21205 United States, New Jersey New Jersey Medical School Clinical Research Center CRS Newark, New Jersey, United States, 07103 United States, New York Weill Cornell Chelsea CRS New York, New York, United States, 10010 United States, Ohio Cincinnati Clinical Research Site Cincinnati, Ohio, United States, 45219 United States, Pennsylvania Penn Therapeutics, CRS Philadelphia, Pennsylvania, United States, 19104 University of Pittsburgh CRS Pittsburgh, Pennsylvania, United States, 15213 United States, Rhode Island The Miriam Hospital Clinical Research Site (TMH CRS) CRS Providence, Rhode Island, United States, 02906 United States, Texas Trinity Health and Wellness Center CRS Dallas, Texas, United States, 75208 Houston AIDS Research Team CRS Houston, Texas, United States, 77030 United States, Washington University of Washington AIDS CRS Seattle, Washington, United States, 98104-9929 Puerto Rico Puerto Rico AIDS Clinical Trials Unit CRS San Juan, Puerto Rico, 00935 Less <<
NCT03201718 - Recruiting December 31, 2022 -
NCT02786537 Chronic Hepatitis C Phase 4 Active, not recruiting February 2022 -
NCT01995071 Chronic Hepatitis C ... More >> Hepatitis C Virus Compensated Cirrhosis Less << Phase 2 Completed - -
NCT02486406 Chronic Hepatitis C Infection Phase 2 Active, not recruiting November 26, 2020 United States, California ... More >> Univ California, San Francisco /ID# 136774 San Francisco, California, United States, 94143-2204 United States, Colorado Children's Hospital Colorado /ID# 137017 Aurora, Colorado, United States, 80045 United States, Florida University of Florida /ID# 136830 Gainesville, Florida, United States, 32610 Florida Hospital /ID# 167663 Orlando, Florida, United States, 32803 United States, Indiana Indiana University /ID# 137015 Indianapolis, Indiana, United States, 46202 United States, Massachusetts Boston Childrens Hospital /ID# 137174 Boston, Massachusetts, United States, 02115 United States, New York Columbia Univ Medical Center /ID# 136431 New York, New York, United States, 10032-3725 United States, Pennsylvania Children's Hosp Philadelphia /ID# 137018 Philadelphia, Pennsylvania, United States, 19104 United States, Texas Baylor College of Medicine /ID# 136590 Houston, Texas, United States, 77030-2608 United States, Washington Seattle Children's Hospital /ID# 137019 Seattle, Washington, United States, 98105 Belgium Cliniques Universitaires Saint Luc /ID# 136910 Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium, 1200 UZ Leuven /ID# 136911 Leuven, Belgium, 3000 Germany Charité Universitätsmedizin Campus Mitte /ID# 141620 Berlin, Germany, 10117 Universitätsklinikum Freiburg /ID# 141618 Freiburg, Germany, 79106 Helios Klinikum Wuppertal /ID# 142883 Wuppertal, Germany, 42283 Puerto Rico San Jorge Children Hospital /ID# 136832 San Juan, Puerto Rico, 00912-3310 Spain Hospital Univ Vall d'Hebron /ID# 137098 Barcelona, Spain, 08035 Hospital Sant Joan de Deu /ID# 137096 Esplugues de Llobregat, Spain, 08950 Hospital Universitario La Paz /ID# 137094 Madrid, Spain, 28046 Hospital Universitario La Fe /ID# 137097 Valencia, Spain, 46026 Less <<
NCT02461745 Hepatitis C, Chronic Phase 4 Active, not recruiting July 2018 United States, California ... More >> Kaiser Permanente Medical Center Irvine, California, United States, 92618 Kaiser Permanente Medical Center Los Angeles, California, United States, 90027 Kaiser Permanente Medical Center San Diego, California, United States, 92154 Kaiser Permanente Medical Center San Marcos, California, United States, 92078 Less <<
NCT02874066 Hepatitis Viruses Phase 4 Active, not recruiting December 20, 2018 Taiwan ... More >> Ditmanson Medical Foundation Chia-Yi Christian Hospital Chiayi City, Taiwan National Taiwan University Hospital, Yun-Lin Branch Douliu, Taiwan China Medical University Hospital Taichung, Taiwan Taichung Veterans General Hospital Taichung, Taiwan National Cheng Kung University Hospital Tainan, Taiwan National Taiwan University Hospital Taipei, Taiwan Taipei City Hospital, Ren-Ai Branch Taipei, Taiwan Tri-Service General Hospital, National Defense Medical Center Taipei, Taiwan Less <<
NCT02582671 - Completed - Ireland ... More >> St Vincent's University Hosp Dublin, Ireland, D04 T6F4 Mater Misericordiae Univ Hosp Dublin, Ireland, D07 R2WY St. James Hospital Dublin, Ireland, D08 E9P6 Beaumont Hospital Dublin, Ireland, D09 XR63 University Hospital Galway Galway, Ireland, H91 YR71 Less <<
NCT03003338 Hepatitis C, Chronic Phase 4 Unknown December 2018 Germany ... More >> Hannover Medical School Recruiting Hannover, Germany, 30625 Contact: Heiner Wedemeyer, Prof. Dr.          Contact: Markus Cornberg, Prof. Dr.          Principal Investigator: Heiner Wedemeyer, Prof. Dr. Less <<
NCT02581189 - Completed - -
NCT01995071 - Completed - -
NCT03050905 HCV Coinfection Phase 4 Recruiting February 2018 Israel ... More >> Haemek medical center Recruiting Afula, Israel Contact: Rawi Hazzan, Dr       ravih@clalit.org.il Less <<
NCT02618928 - Completed - -
NCT02634008 Hepatitis C, Acute Phase 3 Recruiting December 2022 Australia, New South Wales ... More >> St Vincent's Hospital Recruiting Sydney, New South Wales, Australia, 2010 Contact: Rebecca Hickey    +61 2 8382 4981    rhickey@stvincents.com.au    Principal Investigator: Gregory Dore, MBS PhD          Sub-Investigator: Gail Matthews, MBBS PhD          Australia, South Australia Royal Adelaide Hospital Recruiting Adelaide, South Australia, Australia, 5000 Contact: Catherine Ferguson    +61 8 8222 5635    catherine.ferguson@health.sa.gov.au    Principal Investigator: David Shaw          Australia, Victoria Alfred Hospital Recruiting Melbourne, Victoria, Australia, 3004 Contact: Michelle Hagenauer    03-9282 2261    gaclinresearch@alfred.org.au    Principal Investigator: Margaret Hellard          New Zealand Auckland City Hospital Recruiting Auckland, Grafton, New Zealand, 1023 Contact: Victoria Oliver    +64 9 307 4949 ext 22917    VictoriaOl@adhb.govt.nz    Principal Investigator: Ed Gane, MD FRACP          United Kingdom Barts and London Recruiting London, United Kingdom, EC1A 7BE Contact: Chloe Orkin, MBBCh FRCP       chloe.orkin@bartshealth.nhs.uk    Principal Investigator: Chloe Orkin, MBBCh FRCP          Royal Free Hospital Recruiting London, United Kingdom, NW3 2QG Contact: Sanjay Bhagani, MBChB    +44 20 7794 0500 ext 36285    s.bhagani@nhs.net    Principal Investigator: Sanjay Bhagani, MBChB          Guy's and St Thomas' Hospital Recruiting London, United Kingdom, SE1 7EH Contact: Ranjababu Kulasegeram       gpliaisonlbh@hcahealthcare.co.uk    Principal Investigator: Ranjababu Kulasegeram          Chelsea and Westminster Hospital Recruiting London, United Kingdom, SW10 9NH Contact: Mark Nelson, MD    +442087465610    m.nelson@ic.ac.uk    Principal Investigator: Mark Nelson, MD          St Mary's Hospital Recruiting London, United Kingdom, W2 1NY Contact: Graham Cooke       g.cooke@imperial.ac.uk    Principal Investigator: Graham Cooke Less <<
NCT02807402 - Completed - Romania ... More >> Brasov County Clinical Emergency Hospital /ID# 154186 Brasov, Romania Brasov Infectious Diseases Hospital /ID# 154188 Brasov, Romania National Institute of Infectious Diseases "Matei Bals" /ID# 152376 Bucharest, Romania, 21105 National Institute of Infectious Diseases "Matei Bals" /ID# 152385 Bucharest, Romania, 21105 National Institute of Infectious Diseases "Matei Bals" /ID# 152386 Bucharest, Romania, 21105 National Institute of Infectious Diseases "Matei Bals" /ID# 152390 Bucharest, Romania, 21105 National Institute of Infectious Diseases "Matei Bals" /ID# 154187 Bucharest, Romania, 21105 Institutul Clinic Fundeni /ID# 152387 Bucharest, Romania, 22328 Institutul Clinic Fundeni /ID# 152388 Bucharest, Romania, 22328 Institutul Clinic Fundeni /ID# 153377 Bucharest, Romania, 22328 Clinical Hospital of Infectious Diseases and Pneumoftisiolog /ID# 152367 Bucharest, Romania, 30223 Clinical Hospital of Infectious and Tropical Dis Victor Babe /ID# 152383 Bucharest, Romania, 30303 Clinical Hospital of Infectious and Tropical Dis Victor Babe /ID# 152389 Bucharest, Romania, 30303 Badea Medica Gastroenterology Clinic /ID# 152380 Cluj Napoca, Romania, 400375 Medical Center of Gastroenterology, Hepatology and Endoscopy /ID# 152382 Cluj Napoca, Romania, 410072 Constanta County Clinical Emergency Hospital /ID# 152368 Constanta, Romania, 900635 Constanta CF Clinical Hospital /ID# 152371 Constanta, Romania, 900697 Iasi Gastroenterology and Hepatology Institute /ID# 152378 Iasi, Romania, 700463 Iasi Gastroenterology and Hepatology Institute /ID# 152375 Iasi, Romania, 700506 Oradea County Clinical Emergency Hospital /ID# 152366 Oradea, Romania, 410167 Algomed Policlinic /ID# 152370 Timisoara, Romania, 300002 Timisoara County Clinical Emergency Hospital /ID# 152369 Timisoara, Romania, 300736 Less <<
NCT02646111 Hepatitis C Phase 3 Not yet recruiting January 2019 -
NCT02581163 - Completed - Belgium ... More >> CUB Hospital Erasme Brussels, Bruxelles-Capitale, Belgium, 1070 Cliniques Universitaires Saint Luc Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium, 1200 Grand Hôpital de Charleroi Charleroi, Hainaut, Belgium, 6000 CHU de Liege - Domain Universi Liège, Liege, Belgium, 4000 Algemeen Stedelijk Ziekenhuis Aalst, Oost-Vlaanderen, Belgium, 9300 Centre Hospitalier de Wallonie Picarde Tournai, Wallonne, Region, Belgium, 7500 ZNA Stuivenberg Antwerp, Belgium, 2060 CHU St. Pierre Brussels, Belgium, 1000 CHU Brugmann Brussels, Belgium, 1020 HIS - Bracops Brussels, Belgium, 1070 Hospital Edith Cavell Brussels, Belgium, 1180 HIS Moliere-Longchamp Brussels, Belgium, 1190 UZ Antwerp Edegem, Belgium, 2650 Z.O.L - Campus St. Jan Genk, Belgium, 3600 AZ Maria Middelares Ghent, Belgium, 9000 UZ Leuven Leuven, Belgium, 3000 Clinique St Joseph Liege, Belgium, 4000 C.H.U.de Mons Borinage Mons, Belgium, 7000 AZ-Delta Roeselare, Belgium, 8800 UCL Mont Godinne Yvoir, Belgium, 5530 Less <<
NCT02636608 - Completed - Hungary ... More >> Dél-pesti Centrumkórház- Országos Hematológiai és Infektológiai Intézet /ID# 146058 Budapest IX, Budapest, Hungary, 1097 Markusovszky Egyetemi Oktatókórház /ID# 146064 Szombathely, Vas, Hungary, 9700 Magyr Imre Korhaz /ID# 146069 Ajka, Hungary, 8400 Dr. Rethy Pal Korhaz /ID# 146067 Bekescsaba, Hungary, 5600 Semmelweis Egyetem /ID# 146057 Budapest, Hungary, 1085 Semmelweis Egyetem /ID# 146059 Budapest, Hungary, 1085 Budai Hepatologiai Centrum /ID# 146055 Budapest, Hungary, 1111 Szent Janos Korhaz /ID# 146063 Budapest, Hungary, 1125 Kenezy Gyula Korhaz es Rendelo /ID# 146068 Debrecen, Hungary, 4031 Debreceni Egyetem Klinikai Koz /ID# 146065 Debrecen, Hungary, 4032 Bekes Megyei Pandy Kalman Korh /ID# 146061 Gyula, Hungary, 5700 Somogy Megyei Kaposi Mor Oktat /ID# 146056 Kaposvár, Hungary, 7400 Fejer Megyei Szent Gyorgy Korh /ID# 146062 Szekesfehervar, Hungary, 8000 Jasz-Nagykun-Szolnok Megyei /ID# 146066 Szolnok, Hungary, 5004 Less <<
NCT02950870 Chronic Hepatitis, C Virus Phase 4 Not yet recruiting December 2019 Italy ... More >> Gastroenterology Unit Not yet recruiting Modena, Italy, 41124 Contact: Erica Villa, Prof.    +390594225308    erica.villa@unimore.it    Contact: VERONICA BERNABUCCI, MD    +390594223109    veronica.bernabucci@gmail.com    Principal Investigator: Erica Villa, Prof. Less <<
NCT02803138 - Completed - Israel ... More >> Soroka Medical Center /ID# 169357 Be'er Sheva, HaDarom, Israel, 84101 Rabin Medical Center /ID# 153696 Petakh Tikva, Tel-Aviv, Israel, 4941492 Rabin Medical Center /ID# 158648 Petakh Tikva, Tel-Aviv, Israel, 4941492 Tel Aviv Sourasky Medical Ctr /ID# 153693 Tel Aviv-Yafo, Tel-Aviv, Israel, 6423906 Ha'Emek Medical Center /ID# 153695 Afula, Israel, 18341 Soroka Medical Ctr /ID# 153697 Be'er Sheva, Israel, 84101 Assaf Harofeh Medical Center /ID# 153708 Be'er Ya'akov, Israel, 70300 Maccabi Health Services /ID# 158647 Gush Dan, Israel, 7565016 Hillel Yaffe Medical Center /ID# 153702 Hadera, Israel, 38100 Rambam Health Care Campus /ID# 153694 Haifa, Israel, 3109601 Bnai Zion Medical Center /ID# 153700 Haifa, Israel, 3339419 The Lady Davis Carmel MC /ID# 153692 Haifa, Israel, 3436212 The Edith Wolfson Medical Cent /ID# 153706 Holon, Israel, 58100 Shaare Zedek Medical Center /ID# 153699 Jerusalem, Israel, 91031 Hadassah /ID# 153701 Jerusalem, Israel, 91120 Meir Medical Center /ID# 153698 Kfar Saba, Israel, 44281 Western Galilee Medical Center /ID# 153705 Nahariya, Israel, 22100 Sheba Medical Center /ID# 153707 Ramat Gan, Israel, 5262100 Less <<
NCT02582658 - Completed - Austria ... More >> LKH Hoergas-Enzenbach /ID# 145947 Gratwein-Strassengel, Austria, 8112 Landeskrankenhaus Universitaetsklinikum Graz /ID# 145948 Graz, Austria, 8036 Academic Teaching Hospital /ID# 145939 Hall, Austria, 6060 Medical University of Innsbruck /ID# 145938 Innsbruck, Austria, 6020 AKH Linz /ID# 145942 Linz, Austria, 4020 Krankenhaus der Elisabethinen Linz GmbH /ID# 145941 Linz, Austria, A-4020 Krankenanstalt Rudolfstiftung /ID# 145945 Vienna, Austria, 1030 Medical University of Vienna /ID# 145943 Vienna, Austria, 1090 SMZ-Sud-Kaiser-Franz-Josef-Spital der Stadt Wien /ID# 145946 Vienna, Austria, 1100 Wilhelminenspital der stadt Wien /ID# 145944 Vienna, Austria, 1160 Less <<
NCT02817594 - Completed - Netherlands ... More >> Noordwest Ziekenhuisgroep Alkmaar, Netherlands, 1815 JD OLVG Locatie West Amsterdam, Netherlands, 1061 AE Vrije Univ Medisch Centrum Amsterdam, Netherlands, 1081 HV Albert Schweitzer Ziekenhuis Dordrecht, Netherlands, 3318 AT Catharina ziekenhuis Eindhoven, Netherlands, 5623 Univ Med Center Groningen Groningen, Netherlands, 9713 GZ Leids Universitair Medisch Cen Leiden, Netherlands, 2333 ZA Maastricht University Med Ctr Maastricht, Netherlands, 6229 HX Radbound University Medical Ce Nijmegen, Netherlands, 6526 GA Erasmus Medisch Centrum Rotterdam, Netherlands, 3015 CE Maasstad Ziekenhuis Rotterdam, Netherlands, 3079 DZ UMC Utrecht Utrecht, Netherlands, 3584 CX Less <<
NCT02851069 - Completed - Colombia ... More >> Fundacion Cardioinfantil /ID# 155724 Bogota, Colombia Cic Cali /Id# 163986 Cali, Colombia, 760001 Centro Medico Imbanaco de Cali /ID# 163660 Cali, Colombia Pharos Centro de Estudios Clin /ID# 161709 Cartagena, Colombia, 130013 IPS Medicos Internistas Del Ca /ID# 163987 Manizales, Colombia, 170004 Fundacion Hospitalaria San Vin /ID# 167437 Medellín, Colombia, 050010 Less <<
NCT02798315 - Completed - Kuwait ... More >> Adan Hospital /ID# 150776 Adan, Kuwait Mubarak Hospital /ID# 150772 Hawalli, Kuwait Mubarak Hospital /ID# 150773 Hawalli, Kuwait Mubarak Hospital /ID# 150774 Hawalli, Kuwait Amiri Hospital /ID# 150775 Kuwait, Kuwait Less <<
NCT02725866 - Completed - Greece ... More >> General University Hospital of Alexandroupolis /ID# 149494 Alexandroupolis, Greece, 68100 General University Hospital of Alexandroupolis /ID# 153776 Alexandroupolis, Greece, 68100 Evangelismos General Hospital of Athens /ID# 151259 Athens, Greece, 10676 General Hospital of Athens, Evangelismos /ID# 149510 Athens, Greece, 10676 General Hospital of Athens "Ippokratio" /ID# 151260 Athens, Greece, 11527 General Hospital of Athens "Laiko" /ID# 149498 Athens, Greece, 11527 General and Oncology Hospital of Kifisia Agioi Anargyroi /ID# 149509 Athens, Greece, 14564 Iasso General Hospital /ID# 149503 Athens, Greece, 15562 University General Hospital of Heraklion /ID# 151436 Heraklion, Greece, 71500 University General Hospital of Ioannina /ID# 151257 Ionnina, Greece, 45500 Regional General University Hospital of Larissa /ID# 151255 Larisa, Greece, 41111 Mitera Private Hospital /ID# 149504 Marousi, Greece, P.C.15123 Regional General University Hospital of Patras /ID# 151258 Patras, Greece, 26504 Agios Panteleimon General Hospital of Nikea /ID# 149507 Pireaus, Greece, 18454 Agios Panteleimon General Hospital of Nikea /ID# 149508 Pireaus, Greece, 18454 General Hospital of Piraeus "Tzaneio" /ID# 149506 Pireaus, Greece, 18536 General Hospital of Rhodes /ID# 151256 Rhodes, Greece, 85100 Bioclinic Thessaloniki /ID# 149497 Thessaloniki, Greece, 54622 University General Hospital "AHEPA" /ID# 149505 Thessaloniki, Greece, 54636 University General Hospital "AHEPA" /ID# 153774 Thessaloniki, Greece, 54636 General Hospital of Thessaloniki Papageorgiou /ID# 149495 Thessaloniki, Greece, 56429 Interbalkan Center of Thessaloniki /ID# 149496 Thessaloniki, Greece, 57001 Less <<
NCT02498015 Hepatitis C, Chronic Phase 4 Active, not recruiting September 2020 Australia, New South Wales ... More >> The Kirby Institute, University of New South Wales Australia Sydney, New South Wales, Australia, 2052 Less <<
NCT01854697 Chronic Hepatitis C Infection Phase 3 Completed - -
NCT03053180 - Completed - Russian Federation ... More >> South-Ural State Med. Academy Chelyabinsk, Russian Federation, 454052 KOGBUZ Kirovsk Infect Hosp Kirov, Russian Federation, 610008 Specialized Clinical Infectiou Krasnodar, Russian Federation, 350000 Orenburg Regional Clinical Hos Orenburg, Russian Federation, 460018 LLC Medical Company Samara, Russian Federation, 443063 GBOU VPO Saratov State Med Uni Saratov, Russian Federation, 410012 Ulyanovsk Regional Clin Hosp Ulyanovsk, Russian Federation, 432018 Less <<
NCT02615145 - Completed - Germany ... More >> Universitatsklinikum Munster Munster, Niedersachsen, Germany, 48149 Univ Hosp Schleswig-Holstein Kiel, Schleswig-Holstein, Germany, 24105 PZB Aachen Aachen, Germany, 52062 Drs. Brudler, Heinrich und Ban Augsburg, Germany, 86150 Charité Universitätsmedizin Campus Mitte Berlin, Germany, 10117 Praxis City Ost Berlin, Germany, 10243 Praxisgemeinschaft Bieniek Berlin, Germany, 10243 Carganico, Baumgarten, Dupke Berlin, Germany, 10439 Gastroenterologie am Bayerisch Berlin, Germany, 10825 Koeppe, Kreckel, Berlin, DE Berlin, Germany, 10961 Leberzentrum am Checkpoint Berlin, Germany, 10969 Praxis Dr. Naumann Berlin, Germany, 14057 Praxis Dr. Heuchel Chemnitz, Germany, 09111 Scholten, Cologne, DE Cologne, Germany, 50674 Zehnter, Dortmund, DE Dortmund, Germany, 44263 Mauss, Schmutz, Hegener, Athma Dusseldorf, Germany, 40237 Universitaetsklinikum Essen- Essen, Germany, 45147 Rambow & Partner, Frankfurt, D Frankfurt, Germany, 60313 Stern, Frankfurt, DE Frankfurt, Germany, 60316 Bethanien-Krankenhaus Frankfurt, Germany, 60389 Praxis Dr. Teuber Frankfurt, Germany, 60594 Universitaetskl. Gieben u.Marb Gieben, Germany, 35392 Friese and Cseke, Giessen, DE Giessen, Germany, 35390 Krankenhausapotheke der Asklepios Kliniken Hamburg GmbH Hamburg, Germany, 22453 Tappe/Miks/Delker, Hamm, DE Hamm, Germany, 59065 Praxis Dres. Heiken/Holm/Kuhlm Hannover, Germany, 30159 Group Practice Gastroenterolog Herne, Germany, 44623 Moog/Hauenstein, Kassel, DE Kassel, Germany, 34127 Gastro.-Hepatologisches Zentru Kiel, Germany, 24146 Zentrum für Innere Medizin Konstanz, Germany, 78464 Praxis Dr. Schiefke Leipzig, Germany, 04103 Boerner, Mainz, DE Mainz, Germany, 55116 Univ Johannes Gutenberg Mainz, Germany, 55131 Gastro. Schwerpunkt Praxis Mannheim, Germany, 68161 Medizinische Klinik II Mannheim, Germany, 68167 Universitatsmedizin Mannheim Mannheim, Germany, 68167 Praxis Dr. Backmund Munich, Germany, 80331 Leberzentrum Munich Munich, Germany, 80336 Centr. für Interdiszipl. Med. Munster, Germany, 48143 Gastroenterologie Offenburg, Germany, 77654 Kirchner/Sprenger/Joergensen/S Remscheid, Germany, 42859 Group Practice, Drs. Schnaitma Stuttgart, Germany, 70197 Universitatsklinikum Tubingen Tuebingen, Germany, 72076 Loehr, Wiesbaden, DE Wiesbaden, Germany, 65185 Zentrum Innere Medizin (ZIM) Wuerzburg, Germany, 97080 Less <<
NCT01773070 - Completed - -
NCT03002818 - Completed - Switzerland ... More >> Kantonsspital St. Gallen St. Gallen, Sankt Gallen, Switzerland, 9007 Inselspital, Universitaetsklin Bern, Switzerland, 3010 Fondazione Epatocentro Ticino Lugano, Switzerland, 6900 Hopital Neuchatelois Neuchatel, Switzerland, CH-2000 Universitaetsspital Zuerich Zurich, Switzerland, 8091 Less <<
NCT02442271 Chronic Hepatitis C Infection Phase 3 Completed - -
NCT01773070 Hepatitis C Phase 3 Completed - -
NCT01854697 - Completed - -
NCT02669940 - Completed - -
NCT02640547 - Completed - -
NCT02442271 - Completed - -
NCT01563536 Chronic Hepatitis C Infection Phase 2 Completed - United States, California ... More >> Site Reference ID/Investigator# 68002 Bakersfield, California, United States, 93301 United States, Florida Site Reference ID/Investigator# 67383 Orlando, Florida, United States, 32809 United States, Maryland Site Reference ID/Investigator# 67382 Annapolis, Maryland, United States, 21401 United States, New York Site Reference ID/Investigator# 67385 Poughkeepsie, New York, United States, 12601 Less <<
NCT02669940 - Completed - -
NCT02356562 - Completed - -
NCT02504099 - Terminated(Study stopped due t... More >>o low enrollment) Less << - -
NCT02504099 Chronic Hepatitis C Infection Phase 3 Terminated(Study stopped due t... More >>o low enrollment) Less << - -
NCT01563536 - Completed - -
NCT02356562 Chronic Hepatitis C Infection Phase 2 Completed - -
NCT02442284 Chronic Hepatitis C ... More >> Cirrhosis Hepatitis C Virus Less << Phase 3 Completed - -
NCT02609659 Hepatitis C Virus (HCV) Phase 3 Completed - -
NCT02640547 - Completed - -
NCT01782495 Chronic Hepatitis C Infection Phase 2 Completed - -
NCT02609659 - Completed - -
NCT02207088 - Completed - -
NCT01782495 - Completed - -
NCT02442284 - Completed - -
NCT02219477 Chronic Hepatitis C ... More >> Decompensated Cirrhosis Hepatitis C Virus Less << Phase 3 Completed - -
NCT02399345 Chronic Hepatitis C Virus (HCV... More >> Infection Genotype 1) Less << Phase 3 Completed - -
NCT02207088 Chronic Hepatitis C ... More >> Hepatitis C Virus Compensated Cirrhosis Severe Renal Impairment End-stage Renal Disease Less << Phase 3 Completed - -
NCT02487199 Hepatitis C Virus (HCV) Phase 3 Completed - -
NCT02399345 - Completed - -
NCT03122132 - Completed - Spain ... More >> Carrion, Jose Antonio, PhD Barcelona, Spain, 08003 Less <<
NCT02219477 - Completed - -
NCT01854528 Chronic Hepatitis C Infection Phase 3 Completed - -
NCT01854528 - Completed - -
NCT00696904 HCV Infection Phase 1 Completed - -
NCT02487199 - Completed - -
NCT02493855 Chronic Hepatitis C ... More >> Hepatitis C (HCV) Hepatitis C Genotype 1a Less << Phase 2 Completed - -
NCT00768690 HCV Infection Phase 1 Completed - United States, Illinois ... More >> Site Reference ID/Investigator# 12701 Waukegan, Illinois, United States, 60085 Less <<
NCT02216422 Chronic Hepatitis C Virus (HCV... More >>) Infection Less << Phase 3 Completed - -
NCT02216422 - Completed - -
NCT02219503 Chronic Hepatitis C Infection ... More >> Compensated Cirrhosis Less << Phase 3 Completed - -
NCT01464827 Chronic Hepatitis C ... More >> Hepatitis C (HCV) Hepatitis C Genotype 1 Less << Phase 2 Completed - -
NCT02493855 - Completed - -
NCT02476617 Chronic Hepatitis C ... More >> Hepatitis C (HCV) Hepatitis C Genotype 1a Less << Phase 3 Completed - -
NCT01464827 - Completed - -
NCT02476617 - Completed - -
NCT02582632 Hepatitis C Infection ... More >> Hepatitis C Virus Less << Phase 3 Completed - -
NCT02734173 Hepatitis C Phase 4 Recruiting December 2018 Canada, Ontario ... More >> The Ottawa Hospital, General Campus Recruiting Ottawa, Ontario, Canada Contact: Curtis Cooper, MD    613-737-8924       Principal Investigator: Curtis Cooper, MD Less <<
NCT02582632 - Completed - -
NCT01715415 Chronic Hepatitis C Infection Phase 3 Completed - -
NCT01939197 Hepatitis C Virus Infection ... More >> Human Immunodeficiency Virus Infection Chronic Hepatitis C Compensated Cirrhosis and Non-cirrhotics Less << Phase 2 Phase 3 Completed - -
NCT01715415 - Completed - -
NCT02219503 - Completed - -
NCT00919490 HCV Infections Phase 1 Completed - Japan ... More >> Site Reference ID/Investigator# 19102 Kagoshima, Japan, 890-0081 Less <<
NCT01716585 - Completed - -
NCT01074008 - Completed - -
NCT01716585 Chronic Hepatitis C Infection Phase 3 Completed - -
NCT01833533 - Completed - -
NCT01306617 Chronic Hepatitis C Infection ... More >> Hepatitis C Hepatitis C Virus Less << Phase 2 Completed - United States, California ... More >> Site Reference ID/Investigator# 48263 Los Angeles, California, United States, 90048 United States, Colorado Site Reference ID/Investigator# 48264 Aurora, Colorado, United States, 80045 United States, Florida Site Reference ID/Investigator# 51282 Gainesville, Florida, United States, 32610 United States, Massachusetts Site Reference ID/Investigator# 50425 Springfield, Massachusetts, United States, 01105 United States, Missouri Site Reference ID/Investigator# 50423 Kansas City, Missouri, United States, 64131 United States, New York Site Reference ID/Investigator# 48268 New York, New York, United States, 10016 United States, North Carolina Site Reference ID/Investigator# 50428 Statesville, North Carolina, United States, 28677 United States, Texas Site Reference ID/Investigator# 48266 San Antonio, Texas, United States, 78215 United States, Virginia Site Reference ID/Investigator# 50427 Newport News, Virginia, United States, 23602 United States, Washington Site Reference ID/Investigator# 48265 Seattle, Washington, United States, 98101 United States, Wisconsin Site Reference ID/Investigator# 50424 Madison, Wisconsin, United States, 53792 Less <<
NCT01767116 Chronic Hepatitis C Infection Phase 3 Completed - -
NCT01833533 Chronic Hepatitis C Infection Phase 3 Completed - -
NCT01306617 - Completed - -
NCT01074008 Hepatitis C H... More >>CV Chronic Hepatitis C Infection Hepatitis C Genotype 1 Less << Phase 2 Completed - -
NCT00851890 Chronic Hepatitis C Virus Infe... More >>ction Less << Phase 2 Completed - United States, California ... More >> Site Reference ID/Investigator# 16103 Anaheim, California, United States, 92801 Site Reference ID/Investigator# 16124 Los Angeles, California, United States, 90048 United States, Florida Site Reference ID/Investigator# 16102 Orlando, Florida, United States, 32803 United States, Louisiana Site Reference ID/Investigator# 16105 Baton Rouge, Louisiana, United States, 70808 United States, North Carolina Site Reference ID/Investigator# 16106 Chapel Hill, North Carolina, United States, 27599-7584 United States, Texas Site Reference ID/Investigator# 16107 Dallas, Texas, United States, 75203 Site Reference ID/Investigator# 16123 San Antonio, Texas, United States, 78215 Puerto Rico Site Reference ID/Investigator# 16182 Santurce, Puerto Rico, 00909 Less <<
NCT02167945 Chronic Hepatitis C Virus (HCV... More >>) Infection Genotype 1 Less << Phase 3 Active, not recruiting May 5, 2020 -
NCT01767116 - Completed - -
NCT00851890 - Completed - -
NCT00909636 HCV Infection Phase 1 Completed - United States, Illinois ... More >> Site Reference ID/Investigator# 20081 Waukegan, Illinois, United States, 60085 Less <<
NCT02219490 Chronic Hepatitis C Virus (HCV... More >>) Infection Genotype 1 Less << Phase 3 Active, not recruiting May 13, 2021 -
NCT01939197 - Completed - -
NCT00895102 HCV Infection Phase 1 Completed - United States, Illinois ... More >> Site Reference ID/Investigator# 19441 Waukegan, Illinois, United States, 60085 Less <<
NCT02517515 - Completed - -
NCT00726882 - Completed - -
NCT02517528 Chronic Hepatitis C Virus (HCV... More >>) Less << Phase 3 Completed - -
NCT02517515 Hepatitis C Virus (HCV) Phase 3 Completed - -
NCT00726882 HCV Infection Phase 2 Completed - United States, California ... More >> Site Reference ID/Investigator# 17665 Anaheim, California, United States, 92801 Site Reference ID/Investigator# 17367 Los Angeles, California, United States, 90036 Site Reference ID/Investigator# 17672 Los Angeles, California, United States, 90048 United States, Florida Site Reference ID/Investigator# 10381 Orlando, Florida, United States, 32803 United States, Louisiana Site Reference ID/Investigator# 17667 Baton Rouge, Louisiana, United States, 70808 United States, Texas Site Reference ID/Investigator# 14461 San Antonio, Texas, United States, 78215 Puerto Rico Site Reference ID/Investigator# 11141 Santurce, Puerto Rico, 00909 Less <<
NCT02517528 - Completed - -
NCT01911845 - Completed - -
NCT01704755 Chronic Hepatitis C Infection ... More >> Compensated Cirrhosis Less << Phase 3 Completed - -
NCT02534870 Healthy Volunteer Phase 1 Completed - China ... More >> Site Reference ID/Investigator# 137655 Shanghai, China, 200031 Less <<
NCT01674725 Chronic Hepatitis C Infection Phase 3 Completed - -
NCT01704755 - Completed - -
NCT01911845 Chronic Hepatitis C Infection ... More >> Chronic Hepatitis C Less << Phase 2 Completed - -
NCT02052349 Relative Bioavailability PHASE1 COMPLETED 2025-12-13 Site Reference ID/Investigator... More >># 118435, Nottingham, NG11 6JS, United Kingdom Less <<
NCT01674725 - Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.03mL

0.41mL

0.20mL

10.13mL

2.03mL

1.01mL

20.26mL

4.05mL

2.03mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories